申请人:Endosome Therapeutics, Inc.
公开号:US20200383985A1
公开(公告)日:2020-12-10
The present invention relates generally to compounds capable of inhibiting Protease Activated Receptor-2 (PAR
2
), and uses thereof. More specifically, the present invention relates to inhibitors of PAR
2
, to their preparation, and to their use in the treatment of diseases and disorders mediated by PAR
2
signaling.